Turnstone Biologics Corp. Common Stock (TSBX) — Cash Flow Quality Index
Turnstone Biologics Corp. Common Stock (TSBX) has a Cash Flow Quality Index of -252.50x as of March 2023. Operating cash flow of $-17.17 Million is below net income of $68.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Turnstone Biologics Corp. Common Stock (TSBX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Turnstone Biologics Corp. Common Stock Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Turnstone Biologics Corp. Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Turnstone Biologics Corp. Common Stock.
Annual Cash Flow Quality Index for Turnstone Biologics Corp. Common Stock (2021–2021)
Year-by-year earnings quality comparison for Turnstone Biologics Corp. Common Stock.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -1.37x | $-45.63 Million | $33.27 Million | — |